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(57) ABSTRACT 
A Gram-negative bacterium useful for genetically engineer- 
ing plants is provided. The Gram-negative bacterium con- 
tains, as part of genome, an inducible regulatory sequence 
operatively linked to a nucleotide sequence encoding a 
levansucrase. Alternatively, the Gram-negative bacterium 
comprises a recombinant nucleic acid construct containing 
an inducible regulatory sequence operatively linked to a 
nucleotide sequence encoding a levansucrase. Also provided 
are recombinant nucleic acid constructs comprising an 
inducible regulatory sequence operatively coupled to a 
nucleotide sequence encoding a levansucrase and a method 
for transforming plants using the Gram-negative bacterium 
of the present invention. 
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COUNTER SELECTION STRATEGY FOR 
GRAM-NEGATIVE BACTERIA 
[0001] This application is a divisional of U.S. patent 
application Ser. No. 091924,101, filed Aug. 7, 2001, which 
claims the benefit of provisional U.S. Patent Application Ser. 
No. 601223,920, filed Aug. 9, 2000. 
BACKGROUND 
[0002] Agrobacterium is a genus of soil Gram-negative 
bacteria that are widely used for the introduction of exog- 
enous DNA into plants. The use of Agrobacterium species 
for DNA transfer is based on their natural ability to transfer 
DNA sequences into the genomes of plants. The most widely 
used species of Agrobacterium is A. tumefaciens the causal 
agent of the neoplastic disease crown gall in plants. A 
closely related species, A. rhizogenes, induces hairy root 
disease and also has been used for DNA transfer to plant 
genomes, but to a lesser extent. The ability of these bacteria 
to transfer DNA into plants depends on the presence of large 
plasmids (>I00 kb) within the cells. These plasmids are 
referred to as the Ti (Tumor inducing) or Ri (Root inducing) 
in A. tumefaciens and A. rhizogenes, respectively. The 
mechanism for DNA transfer from the bacterium into the 
plant genome involves the mobilization of specific T-DNA 
(transfer DNA) molecules from the Ti plasmid into the host 
cell. The T-DNAregion is delineated by 25 bp referred to as 
the left and right borders. In pathogenic Agrobacterium 
cells, within the T-DNA element reside genes for the over 
production of auxins and cytokinins which manifest the 
crown gall symptoms. The T-DNA element of pathogenic 
Agrobacterium strains also contains genes for the production 
of opines that are utilized by the bacterium as a nitrogen 
source. 
[0003] Agrobacterium-mediated DNA transfer to plant 
cell genomes is usually conducted with "disarmed" (auxin, 
cytokinin and opine gene sequences removed from the 
T-DNA element) strains. In transformation studies, 
sequences of interest are introduced into the T-DNA region 
of a "disarmed"Agrobacterium strain. This chimeric T-DNA 
element can be carried on a separate, smaller, wide host 
range plasmid referred to as a binary vector or directly 
introduced into the resident "disarmed" Ti plasmid. The first 
step in the basic Agrobacterium-mediated transformation 
protocol, requires the inoculation of plant cells with 
transconjugants of "disarmed"Agrobacterium cells carrying 
the sequences of interest on the chimeric T-DNA element. 
The plant cells are subsequently cultured for a period 
generally ranging from one to seven days in a step of the 
protocol referred to as co-cultivation. Following the co- 
cultivation period, the plant cells are subcultured on regen- 
eration medium for whole plant development. 
[0004] A critical step in this process is the elimination of 
the Agrobacterium cells during plant development. Cur- 
rently, Agrobacterium-mediated DNA transfer protocols 
incorporate antibiotics into the regeneration medium as a 
strategy to counter select Agrobacterium cells. Although 
successful, this approach adds significant cost to the trans- 
formation process. Moreover, there have been reports dem- 
onstrating a negative impact on plant tissue using medium 
supplemented with the antibiotics commonly used to elimi- 
nate Agrobacterium cells such as ticarcillin, cefotaxime, 
carbenicillin or vancomycin. 
[0005] The sacB gene from Bacillus subtilis encodes for 
the enzyme levansucrase, which hydrolyzes sucrose to pro- 
duce the polysaccharide levan, the presence of which causes 
the lysis of several Gram-negative bacteria, and in particular 
Agrobacterium (Gay et al. (1 985)) J. Bacteriol. 164:918- 
921). Expression of sacB is controlled by its regulatory 
sequence sacR. The present inventors have discovered that 
the introduction of a sequence encoding a levansucrase and 
in particular the sacB open reading frame (ORF), under strict 
control of an inducible regulatory sequence allows for the 
selection of Agrobacterium cells without the use of antibi- 
otics. Thus, the present invention overcomes the problems of 
cost and negative effects on plant culture associated with the 
use of antibiotics for counter selection of the Agrobacterium 
cells. 
SUMMARY 
[0006] Among the several aspects of the invention is 
provided a Gram-negative bacterium comprising an induc- 
ible regulatory sequence operatively linked to a nucleotide 
sequence encoding a levansucrase contained within the 
genome of said Gram-negative bacterium. 
[0007] Another aspect provides, a Gram-negative bacte- 
rium comprising a recombinant nucleotide sequence con- 
taining an inducible regulatory sequence other than sacR, 
operatively linked to a nucleotide sequence encoding a 
levansucrase. 
[0008] Yet another aspect provides, a recombinant nucleic 
acid construct comprising an inducible regulatory sequence 
other than sacR, operatively linked to a nucleotide sequence 
encoding a levansucrase. 
[0009] Still another aspect provides, a method for trans- 
forming a plant cell comprising obtaining an Agrobacterium 
strain whose genome contains an inducible regulatory 
sequence operatively linked to a nucleotide sequence encod- 
ing a levansucrase; introducing a DNA construct into a 
T-DNA element of the Agrobacterium; and inoculating at 
least one plant cell with the Agrobacterium containing the 
construct for a time sufficient for mobilization of the T-DNA 
element from the Agrobacterium to the plant genome. 
[0010] Another aspect provides, a method for transform- 
ing a plant cell comprising obtaining an Agrobacterium 
strain comprising a first recombinant nucleic acid construct 
containing an inducible regulatory sequence other than 
sacR, operatively linked to a nucleotide sequence encoding 
a levansucrase; introducing a second DNA construct into a 
T-DNA element of the Agrobacterium; and inoculating at 
least one plant cell with the Agrobacterium containing the 
first and second constructs for a time sufficient for mobili- 
zation of the T-DNA element from the Agrobacterium to the 
plant genome. 
[0011] A further aspect provides, a method for counter 
selecting against a Gram-negative bacterium whose genome 
contains an inducible regulatory sequence operatively linked 
to a nucleotide sequence encoding a levansucrase compris- 
ing, introducing, in the presence of sucrose, a suitable 
inducer to cause the production of levansucrase by the 
bacterium resulting in the lysis of the bacterium. 
[0012] Still a further aspect provides, a method for counter 
selecting against a Gram-negative bacterium containing a 
recombinant nucleic acid construct that includes an induc- 
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ible regulatory sequence other than sacR, operatively linked 
to a nucleotide sequence encoding a levansucrase, compris- 
ing introducing, in the presence of sucrose, a suitable 
inducer to cause the production of levansucrase by the 
bacterium resulting in lysis of said bacterium. 
[0013] Another aspect provides, a vector comprising a 
recombinant nucleic acid construct containing an inducible 
regulatory sequence other than sacR, operatively linked to a 
nucleotide sequence encoding a levansucrase. 
Definitions 
[0014] As used herein, "regulatory sequence" means a 
sequence of DNA concerned with controlling expression of 
a gene; e.g. promoters, operators and attenuators. A regula- 
tory sequence, may, potentially operate in conjunction with 
the biosynthetic apparatus of a cell. 
[0015] As used herein, "polynucleotide" and "oligonucle- 
otide" are used interchangeably and mean a polymer of at 
least two nucleotides joined together by a phosphodiester 
bond and may consist of either ribonucleotides or deoxy- 
nucleotides. 
[0016] As used herein, "sequence" means the linear order 
in which monomers in a polymer, for example, the order of 
amino acids in a polypeptide or the order of nucleotides in 
a polynucleotide. 
[0017] As used herein, "peptide", and "protein" are used 
interchangeably and mean a compound that consist of two or 
more amino acids that are linked by means of peptide bonds. 
[0018] As used herein, "levansucrase" means a protein, a 
protein fragment or peptide that has the property of synthe- 
sizing a carbohydrate polymer consisting of repeating fruc- 
tose residues, using sucrose as a substrate. The repeating 
fructose residues may be linked by 8-2-1 linakge or a 8-2-6 
linkage or any combination of the two linkage types. The 
polymer of repeating fructose units may contain one termi- 
nal glucose residue, derived from a sucrose molecule, and at 
least two fructose residues. 
[0019] As used herein, "inducer" means a substance that 
interacts with a regulatory sequence, either directly or indi- 
rectly, to increase the rate of transcription of the nucleotide 
sequence controlled by the regulatory sequence. 
[0020] LB means 10 g tryptone, 5 g yeast extract, 5 g NaCl 
and 1 ml 1N NaOH per liter H,O. 
DETAILED DESCRIPTION 
[0021] The following detailed description is provided to 
aid those skilled in the art in practicing the present invention. 
Even so, this detailed description should not be construed to 
unduly limit the present invention as modifications and 
variations in the embodiments discussed herein can be made 
by those of ordinary skill in the art without departing from 
the spirit or scope of the inventive discovery. 
[0022] All publications, patents, patent applications and 
other references cited in this application are herein incor- 
porated by reference in their entirety as if each publication, 
patent, patent application or other reference were specifi- 
cally and individually indicated to be incorporated by ref- 
erence. 
[0023] The present invention provides a method for trans- 
forming plant cells and constructs and bacteria useful in said 
method. The invention involves the insertion of a sequence 
encoding a levansucrase, and in particular the sacB gene 
ORF, under strict control of an inducible regulatory 
sequence into a Gram-negative bacterium and in particular 
Agrobacterium tumefaciens. The sacB gene encodes levan- 
sucrase (sucrose 2,6,0-D-fructan 6-0-D-glucosyltransferase; 
(IC 2.3.1.10)), a 50 kD enzyme secreted by B. subtilis after 
induction by sucrose. Levansucrase catalyzes transfructory- 
lation from sucrose to various acceptors. The two main 
physiological reactions resulting are, 1) levan synthesis and 
2) sucrose hydrolysis. Since sucrose is the primary carbon 
source used in most plant tissue culture medium formula- 
tions, the present invention allows for the efficient counter 
selection of the bacterium without the use of antibiotic 
supplements. 
[0024] One aspect provides a Gram-negative bacterium 
useful for the transfer of heterologous polynucleotide 
seauences into a host cell. The bacterium has as vart of its 
genome a recombinant nucleic acid sequence comprising an 
inducible regulatory sequence operatively linked to a nucle- 
otide sequence encoding the enzyme levansucrase. Altema- 
tively, the bacterium comprises a recombinant nucleic acid 
sequence comprising an inducible regulatory sequence other 
than sacR, operatively linked to a nucleotide sequence 
encoding the enzyme levansucrase. A nucleic acid sequence 
is operatively linked when it is placed into a functional 
relationship with another nucleic acid sequence. For 
example, DNA for a presequence or secretory leader is 
operatively linked to a DNA element encoding for a 
polypeptide to be expressed as a preprotein which partici- 
pates in the secretion of the polypeptide; a promoter or 
regulatory sequence is operatively linked to a coding 
sequence if it affects the transcription of the coding 
sequence; or a ribosome binding site is operatively linked to 
a coding sequence if it is positioned so as to facilitate 
translation. Any nucleic acid sequence encoding a protein, 
polypeptide or protein fragment that is functional as a 
levansucrase can be used. Numerous sequences encoding 
levansucrase are known in the art and can be found in 
publicly available databases such as those maintained by the 
National Center for Biotechnology Information. Represen- 
tative examples include, without limitation, sequences 
encoding levansucrases obtained from Acetobacter xylinus 
(GenBank AB034152), Gluconacetobacter diazotrophicus 
(GenBank L41732), Zymomonas mobilis (GenBank 
L33402), Paenibacillus polymyza (GenBank AJ133737), 
Rahnella aquatillis (GenBank U91484), Pseudomonas 
syringae (GenBank AF052289), Bacillus stearothermophi- 
lus (GenBank U34874), Bacillus subtilis (GenBank 
X02730) and Bacillus amyoliquefaciens (GenBank 
X52988). Copies of the GenBank records for the listed 
accession numbers are attached and are to be considered part 
of this application. In one embodiment, the polynucleotide 
sequence encoding levansucrase enzyme is the coding 
region of the sacB gene of Bacillus subtilis. As used herein, 
the term "coding region" refers to the nucleotide sequence of 
a gene that is translatable into a polypeptide. Methods for 
producing artificial nucleotide sequences such as by cloning 
or nucleotide synthesis are well known in the art. Such 
sequences are included within the scope of the invention as 
long as they encode a biological equivalent to a levansu- 
crase. 
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[0025] The regulatory sequences can consist of an induc- 
ible promoter, in combination with an operator sequence. As 
used herein, the term "operator" or "operator sequence" 
refers to a polynucleotide sequence to which a repressor 
protein can bind, thereby regulating the expression of a 
gene. Any inducible promoter that is functional within 
Gram-negative bacterium can be used. It is preferred that the 
promoter or combination of the promoter and operator be 
strictly inducible so that there is little or no production of 
levansucrase in the absence of the inducing agent. In one 
preferred embodiment, the regulatory sequence is one that is 
functional in members of the genus Agrobacterium, and in 
particular A. tumefaciens. Examples of suitable regulatory 
sequences include, but are not limited to, the Plac promoter 
and operator of E. coli (SEQ ID NO: I), the nocR gene (SEQ 
ID NO: 3), which encodes for the transcriptional activator of 
Pi2 (noc) (SEQ ID NO: 2), and in the presence of the nocl 
operon (SEQ ID NO: 2) which encodes for the nopaline 
transport system of A. tumefaciens (Von Lintig et al. (1991) 
Molec. Plant Microbe Interaction, 4:370-378) and the P, 
promoter (SEQ ID NO: 5) and araC operator (SEQ ID NO: 
4) of E. coli (Gallegos et al. (1997) Microbiol. Mol. Biol. 
Rev 61:393-410). 
[0026] Another aspect provides a recombinant nucleic 
acid construct comprising an inducible regulatory sequence 
operatively linked to a nucleotide sequence encoding a 
levansucrase. Any previously mentioned regulatory 
sequence or levansucrase encoding sequences can be used, 
although other suitable sequences will be apparent to those 
of ordinary skill in the art and are considered within the 
scope of the present invention. As used herein, "recombinant 
construct" is defined either by its method of production or its 
structure. In reference to its method of production, e.g., a 
product made by a process, the process is use of recombinant 
nucleic acid techniques involving human intervention in the 
nucleotide sequence. Alternatively, in terms of structure, it 
can be a sequence comprising fusion of two or more nucleic 
acid sequences which are not naturally contiguous or opera- 
tively linked to each other. 
[0027] The recombinant constructs of the present inven- 
tion are produced using methods well known to those of 
ordinary skill in the art which can be found, for example, in 
standard texts such as Sambrook et al. Molecular Cloning, 
2nd ed., Cold Spring Harbor Laboratory Press, 1989 and 
Ausubel, et al. Short Protocols in Molecular Biology, yd ed., 
Wiley & Sons, 1995. In general, recombinant constructs are 
produced by a series of restriction enzyme digestions and 
ligation reactions which result in the sequences being 
assembled in the desired configuration. If suitable restriction 
sites are not available, alternative strategies, for example, the 
use of synthetic oligonucleotide linkers and adaptors, which 
are well known to those skilled in the art and described in the 
references cited above, can be employed to assemble the 
desired recombinant constructs. 
[0028] It will be apparent to those of ordinary skill in the 
art, that the precise restriction enzymes, linkers andor 
adaptors required as well as the precise reaction conditions 
will vary with the sequences and cloning strategies used. 
The assembly of recombinant constructs, however, is routine 
in the art and can be readily accomplished by the skilled 
technician without undue experimentation. Non-limiting 
illustrations of the assembly of recombinant constructs use- 
ful in the present invention can be found in the examples that 
follow. 
[0029] Once made, the recombinant constructs can be 
inserted into the genome of Gram-negative bacterium or 
introduced separately on a self replicating plasmid of a 
Gram-negative bacterium used in transforming host cells. In 
one embodiment, the Gram-negative bacterium is Agrobac- 
terium tumefaciens. The inventors have found that insertion 
of the recombinant construct into the genome of the bacterial 
vector is superior to the method of placing the construct in 
A. tumefaciens via a self replicating plasmid. As shown in 
Example 1, it was discovered that a self replicating plasmid 
carrying the sacB coding region was frequently lost resulting 
in overgrowth of the bacterial cells during plant regenera- 
tion. 
[0030] Any method capable of introducing the construct 
into the genome of the bacterial vector can be used. In one 
embodiment, the construct is inserted by the use of homolo- 
gous recombination in particular the method of Ruvkun and 
Ausubel ((1981) Nature, 289:85-88). In this method, a 
mutation, in the form of the recombinant construct of the 
present invention, is directed to a specific locus on the 
chromosome by homologous exchange recombination. Any 
locus which allows the inducible expression of levansucrase 
and does not impede with the DNA transfer machinery can 
be used. In one embodiment, the construct is inserted at the 
tetR1tetA (SEQ ID NO: 9) loci of Agrobacterium (Luo and 
Farrand (1999) J. Bacteriol 181:618-626). 
[0031] Another aspect provides method for transforming a 
plant cell using an Agrobacterium tumefaciens bacterium of 
the present invention as a vector. In general the method 
involves obtaining an A. tumefaciens strain whose genome 
includes a nucleotide sequence encoding a levansucrase 
operatively linked to an inducible regulatory sequence as 
described above or an A. tumefaciens strain that contains a 
recombinant nucleotide sequence encoding a levansucrase 
operatively linked to an inducible regulatory sequence as 
described above. The nucleotide seauence(s) of interest that 
, , 
are to be transferred to the plant cell can be inserted within 
the T-DNA element and introduced either directly to the 
resident Ti plasmid or separately using a binary plasmid 
strategy. Methods for the introduction of exogenous nucle- 
otide sequences into the T-DNA element and the use of the 
derived Agrobacterium transconjugant to transform plant 
cells are well known in the art (see, Maliga et al. Methods 
in Plant Molecular Biology, Cold Spring Harbor Laboratory 
Press, 1995). Once the sequence to be delivered to the plant 
cell is assembled into the T-DNA element and introduced 
either directly to the resident Ti plasmid or via the binary 
vector strategy to the Agrobacterium of the present inven- 
tion, the bacterium is subsequently used to inoculate plant 
cells either by direct injection or by co-cultivating the 
bacterium of the present invention with individual plant cells 
or pieces of plants such as leaf discs. Co-cultivation is 
carried out in medium supplemented with a carbon source, 
preferably glucose, for a sufficient amount of time to allow 
the T-DNA element to be mobilized from the bacterium to 
the plant cell genome. The co-cultivation period is deter- 
mined empirically, but generally ranges from one to seven 
days. Co-cultivation periods may vary for a particular plant 
species, but determinations are routine in the art and can be 
made by one of ordinary skill in the art without undue 
Nov. 23,2006 
experimentation. Following co-cultivation, the transforming 
bacteria are counter selected prior to the regeneration of the 
plant cells to whole plants. Typically, the transforming 
bacteria are removed by using antibiotic supplements to the 
regeneration medium. In the present invention, however, an 
inducing agent that activates the promoter linked to the 
levansucrase coding region is added to sucrose amended 
regeneration medium. Activation of the inducible promoter 
results in the production of levan which causes the lysis of 
the Agrobacterium cells, thus providing efficient counter 
selection strategy. As a result, the regeneration of whole 
plants from the inoculated plant cells can be carried out, in 
the absence of antibiotics typically used to counter select 
Agrobacterium cells, following standard protocols (see, 
Maliga et al. supra). 
[0032] An alternative embodiment provides an Agrobac- 
terium tumefaciens vector in which the nucleotide sequence 
encoding a levansucrase operatively linked to an inducible 
regulatory sequence is contained in the Agrobacterium as 
part of a binary vector system. Binary vector systems and 
their constructions are well known in the art and are 
described, for example, in Maliga et al. supra and The 
Encyclopedia of Molecular Biology, J .  Kendrew, ed., Black- 
well Science, 1994). The resultant Agrobacterium strain can 
subsequently be used to genetically engineer plant cells as 
described above. 
EXAMPLES 
Example 1 
Counter Selection Using sacB in a Binary Vector System 
[0033] The nptl-sacB-sacR loci from the vector pUM24 
(Reid and Collmer (1987) Gene 57:239-246) was subcloned 
as a BamHI fragment into the binary vector pZP112 
(Hajdukiewicz et al. (1994) Plant Molec. Biol. 25:989-994), 
at the BclI site just outside the left border region. The 
resultant counter selection (suicide) vector was referred to as 
pPTN114. The binary vector was mobilized into A. tume- 
faciens strains C58C1 (Koncz and Schell (1986) Mol. Gen 
Genet. 204:383-396) and EHAlO5 (Hood et a1 (1993) Trans- 
genic Research 2:208-218) via tri-parental mating (Ditta et 
a1 (1980) Proc. Natl. Acad. Sci USA 77:7347-7351). The 
C58C1 transconjugant was used for subsequent evaluation 
in tobacco transformations, while the EHAlO5 transconju- 
gant was tested in soybean transformations. 
[0034] Culturing of the C58C1 and EHAlO5 carrying the 
binary vector pPTN114 on LB medium supplemented with 
1% to 3% sucrose was lethal, while LB medium supple- 
mented with 1.5% glucose was conducive to cell growth. 
Tobacco and soybean transformations were initiated to 
evaluate the efficacy of incorporating the sacB locus in a 
binary vector as a counter selection strategy for A. tumefa- 
ciens in the absence of antibiotics. In both plant species, 
Agrobacterium growth was impeded for approximately 10 
days, at which point bacterial growth was observed on the 
plant tissue culture medium containing 3% sucrose. The 
bacteria from the tissue culture failed to grow when trans- 
ferred onto LB medium supplemented with kanamycin. 
These results suggested that the Agrobacterium cells had lost 
the binary vector. 
Example 2 
Counter Selection by Genomic Incorporation of sacB 
[0035] A construct was assembled that specifically tar- 
geted the sacB locus to the tetWtetA (SEQ ID NO: 9) loci 
in A. tumefaciens. An EcoRI fragment from pSWE8.5 bear- 
ing the tetWtetA loci (SEQ ID NO: 9) was subcloned into 
pGEM T-Easy. The resulting plasmid was digested with 
Hind I11 and a 0.5 kb fragment at the tetR locus was replaced 
with the 3.8 kb BamHI insert from pUM24 containing the 
nptI-sacB-sacR region (Reid and Collmer (1987) Gene 
57:239-246). This step was accomplished by annealing after 
adding homopolymeric G and C tails to the vector and insert, 
respectively. The resulting construct was electroporated into 
Agrobacterium strain NTllpEHAlO5 and transformants 
were selected on kanamycin (50 mg1L) LB plates. Since the 
pGEM backbone was not expected to replicate in A. tume- 
faciens, kanamycin resistant transformants were presumed 
to be due to chromosomal integration of the nptI-sacB-sacR 
cassette at the tetWtetA loci (SEQ ID NO: 9). Individual 
colonies were picked and replica plated to kanamycin 
supplemented LB medium with and without sucrose (3% 
wlv). The resulting bacterial patches that showed little or no 
growth on sucrose, but vigorous growth on kanamycin 
alone, were recovered, diluted and spread on kanamycin 
plates to isolate individual colonies. These were again tested 
as before until an isolate that consistently gave no growth on 
sucrose was recovered. 
Example 3 
Use of the E. coli PlacIRepressor System to Control sacB 
Expression 
[0036] The E. coli lactose operon (SEQ ID NO: 1) is 
tightly regulated by the presence of a 21 bp operator that 
resides immediately down stream of the Plac promoter (SEQ 
ID NO: 1). In the absence of 0-galactose sugar, the lac 
repressor will bind to the cis operator and prevent RNA 
polymerase initiation. In the presence of a 0-galactose sugar, 
the lac repressor cannot bind to the operator and thus RNA 
polymerization proceeds. This system may be exploited as a 
strategy for tight regulation of the sacB expression in 
Agrobacterium tumefaciens cells. 
[0037] The sacB open reading frame (ORF) can be sub- 
cloned downstream of the Plac promoter element (SEQ ID 
NO: 1) coupled with the 21 bp operator sequence. The lac1 
cassette (SEQ ID NO: 6) coding for the lac repressor may be 
ligated to the derived sacB cassette. The genetic element 
- - 
carrying the Plac-sacB and lac repressor cassettes can be 
introduced to the chromosome of Agrobacterium tumefa- 
ciens via homologous recombination. The preferred site for 
the recombination event would be the tetWtetA loci (SEQ 
ID NO: 9) of Agrobacterium recently described by Luo and 
Farrand ((1999) J. Bacteriol. 181:618-626). 
[0038] This strategy will be useful for the genetic engi- 
neering of both monocotyledonous and dicotyledonous plant 
species. Various steps are followed in the Agrobacterium- 
mediated transformation of plant species. ~ e i e r a l l ~  the first 
step involves the inoculation of the explant (plant cells or 
tissue segments) with Agrobacterium tumefaciens cells. The 
explant can be leaf segment, cotyledon, stem, root, flower 
part or cells thereof. After a period of one to seven days, 
generally termed the co-cultivation period, the explant is 
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transferred to plant regeneration medium supplemented with 
sucrose as the carbon source. The sacB system in this 
example may be induced by the addition of isopropyl-0-D- 
thiogal-actoside (IPTG) at levels ranging from 0.1 pM up to 
1 mM andor lactose at levels from 0.1 pM to 1 mM. 
Example 4 
Use of the Nopaline-Inducible Marker System to Regulate 
sacB Expression 
[0039] The Pi2(noc) promoter (SEQ ID NO: 2) (Von 
Lintig et al. (1991) Molec. Plant Microbe Interaction 4:370- 
378) from Agrobacterium tumefaciens is induced in the 
presence of nopaline. This regulatory sequence may be 
employed as a strategy to regulate sacB expression in 
Agrobacterium tumefaciens cells. In this example, the sacB 
ORF will be subcloned down stream of the Pi 2(noc) 
promoter (SEQ ID NO: 2). The resultant cassettes preferably 
will be introduced into the chromosome of Agrobacterium 
tumefaciens via homologous recombination. The preferred 
site for recombination is the tetWtetA loci (SEQ ID NO: 9). 
The nocR gene (SEQ ID NO: 3), which encodes for the 
transcriptional activator of pi2(noc) (SEQ ID NO: 2), and 
the nocl operon (SEQ ID NO: 2) which encodes for the 
nopaline transport system can be supplied by the vir region 
of the resident Ti plasmid, or by cloning these two loci onto 
a self-replicating plasmid. In this example the sacB counter 
selection (suicide) system may be induced upon the addition 
of nopaline at levels ranging from 50 pg/L up to 200 pg/L. 
Example 5 
Use of the E. coli araC Regulator to Control sacB Expres- 
sion 
[0040] The E. coli PEA, promoter (SEQ ID NO: 5) is 
highly induced in the presence of L-arabinose. The induction 
of the system is controlled by the presence of a cis acting 
element upstream of the PEA, promoter (SEQ ID NO: 5), 
araC (SEQ ID NO: 4) (Gallegos et al. (1997) Microbiol. 
Molec. Biol. Rev. 61:393-410). This system can be utilized 
to regulate the expression of the sacB in Agrobacterium 
tumefaciens cells by placing the araC cis element (SEQ ID 
NO: 4) just 5' to the PEA, promoter (SEQ ID NO: 5) (Luo 
and Farrand (1999) J. Bacteriol. 181 :618-626); Newman 
and Fuqua (1999) Gene 227:197-203) and subsequently 
subcloning the sacB open reading frame downstream of the 
assembled DNA elements. In this example, counter selection 
of the bacterial cells can be induced following the co- 
cultivation period in plant transformation protocols by 
supplementing the regeneration medium with levels of 
L-arabinose ranging from 5 g/L up to 20 g/L. 
Example 6 
Use of the traCDG Promoter to Control sacB Expression 
[0041] The sacB gene can be placed under the control of 
the traCDG promoter (SEQ ID NO: 7) (Farrand et al., (1 996) 
Bacteriol. 178:4233-4247; Oger et al., (1998) Mol. Micro- 
biol. 27:277-288; Luo and Farrand, (1999) Proc. Natl. Acad. 
Sci. USA 96:9009-9014). Initiation of this promoter is abso- 
lutely dependent upon activated TraR (SEQ ID NO: 7). 
Second, the TraR (SEQ ID NO: 7) will be placed under the 
direct control of an opine-responsive promoter system. We 
will fuse traR (SEQ ID NO: 7) directly to a fragment of DNA 
containing the occ promoter (SEQ ID NO: 8) from the 
octopine-type Ti plasmid pTiR10. This promoter is activated 
by OccR (SEQ ID NO: a), a lysR-like activator in response 
to the opine, octopine (Habeeb, et al., 1991). The occR gene 
(SEQ ID NO: 8) is located directly adjacent to the occ 
promoter (SEQ ID NO: 8) and will be included in the 
recombinant construct. One can provide a copy of traM 
(SEQ ID NO: 7), which encodes for the antiactivator, in the 
traR-pOcc-occ construct. When the two constructs are com- 
bined in an Agrobacterium host, expression of sacB should 
be strongly suppressed in the absence of the opine. However, 
addition of octopine (which will activate expression of traR 
(SEQ ID NO: 7) leading to accumulation of the activator to 
levels that overcome the antiactivator, TraM (SEQ ID NO: 
7)) should strongly induce sacB. 
[0042] The genetic elements described above can be intro- 
duced to a neutral site in the chromosome of Agrobacterium 
tumefaciens, with respect to plant transformation effects, via 
homologous recombination. The preferred site for the 
recombination event would be the tetWtetA loci (SEQ ID 
NO: 9) of Agrobacterium. However, with the imminent 
availability of the genome sequence of Agrobacterium strain 
C58 one should be able to identify alternative sites within 
the chromosome. 
Example 7 
Use of a Second Copy of the sacB Gene 
[0043] To circumvent potential mutational inactivation of 
sacB a second copy of the gene can be provided. To prevent 
recombination between the two copies one can use a sacB 
gene from another bacterium. Possibilities of alternative 
sacB sources include B. stearothermophilus, B. amylolique- 
faciens, or Streptococcus mutans. The sequence for each of 
these is available in the data bases. The alternative sacB gene 
can be fused to a second copy of the TraR-dependent 
traCDG promoter (SEQ ID NO: 7). 
CONCLUSION 
[0044] In light of the detailed description of the invention 
and the examples presented above, it can be appreciated that 
several aspects of the invention are achieved. 
[0045] It is to be understood that the present invention has 
been described in detail by way of illustration and example 
in order to acquaint others skilled in the art with the 
invention, its principles, and practical application. Particular 
formulations and processes of the present invention are not 
limited to the descriptions of the specific embodiments 
presented, but rather the descriptions and examples should 
be viewed in terms of the claims that follow and their 
equivalents. While some of the examples and descriptions 
above include some conclusions about the wav the invention 
may function, the inventors do not intend t i  be bound by 
those conclusions and functions, but put them forth only as 
possible explanations. 
[0046] It is further understood that the specific embodi- 
ments of the present invention as set forth are not intended 
as being exhaustive or limiting of the invention, and that 
many alternatives, modifications, and variations will be 
apparent to those of ordinary skill in the art in light of the 
foregoing examples and detailed description. Accordingly, 
this invention is intended to embrace all such alternatives, 
modifications, and variations that fall within the spirit and 
scope of the following claims. 
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ggcgggtata atagggccgg tgctgaccac c g c a g t g t t c  t t t t c c a c c a  aaagcatctg 
gatcgggacg a t c t g g c t g g  tgggtgccgc a c t t t a t c t t  c t c g c c t t g c  c g c t g t t c g c  
aacggtgaaa accccgaagg ctgtggcggc t taaagac tc  cggacgtcat  gcgcc tcg tg  
t t t a t c t t c g  c c g c c g a t t t  g a t g t c a t c g  c t t c g a a t c a  aacaggtacg agcgt tgaac 
tggaaatcag aacgccagt t  caacggcatc tccaagcgac g c t t t t c g g c  cgatcacgat  
tgcgagcgca t a t t a g c t a t  ggctggaagg tcatgaagga t c a t g g c t g c  cgcgccgaaa 
gccacggtat  ccgcagcaga gact tcgggc aaaagaattg ccggctgaag a a c t t t c g c a  
ccctcgaacg gatcggaaac tgaaaaatcg agccaggggc a t a a t t g t t c  ccggatca tg  
cggggcaggg agcccccgac a t a t a t t g c c  tcaggggcca gaacagcgct gagggaaaat 
cccag tc tgg  c a g t t t c t g g  cccggcccga t t t a t c c a c g  t t a t c t a c a a  g c t c t t g a t t  
g c t g t t c  
What is claimed is: 
1-13. (canceled) 
14. A method for transforming a plant cell comprising, 
a) obtaining an Agrobacterium whose genome contains an 
inducible regulatory sequence operatively linked to a 
nucleotide sequence encoding a levansucrase; 
b) introducing a DNA construct into a T-DNA element of 
said Agrobacterium; and 
c) inoculating at least one plant cell with the Agrobacte- 
rium of (b) for a time suficient for mobilization of the 
T-DNA element from the Agrobacterium to the plant 
genome. 
15. A method for transforming a plant cell comprising, 
a) obtaining an Agrobacterium comprising a first recom- 
binant nucleic acid construct containing an inducible 
regulatory sequence other than sacR, operatively linked 
to a nucleotide sequence encoding a levansucrase; 
b) introducing a second DNA construct into a T-DNA 
element of said Agrobacterium; and 
c) inoculating at least one plant cell with the Agrobacte- 
rium of (b) for a time suficient for mobilization of the 
T-DNA element from the Agrobacterium to the plant 
genome. 
16. (canceled) 
17. The method of claim 14, wherein said regulatory 
sequence comprises the E. coli lactose operon (SEQ ID NO: 
1). 
18. The method of claim 14, wherein said regulatory 
sequence comprises the pi 2(noc) promoter (SEQ ID NO: 2) 
and noc 1 operon (SEQ ID NO: 2). 
19. The method of claim 14, wherein said regulatory 
sequence comprises the P, promoter (SEQ ID NO: 5) and 
the araC cis element (SEQ ID NO: 4). 
20. The method of claim 14, wherein said sequence 
encoding a levansucrase is a sacB open reading frame. 
21-37. (canceled) 
38. The method of claim 14, wherein the regulatory 
sequence comprises the traCDG promoter (SEQ ID NO: 7) 
and the occ promoter (SEQ ID NO: 8). 
39. The method of claim 20, wherein the nucleotide 
sequence encoding a levansucrase contains a second copy of 
a sacB open reading frame. 
40. The method of claim 15, wherein the regulatory 
sequence comprises the traCDG promoter (SEQ ID NO: 7) 
and the occ promoter (SEQ ID NO: 8). 
41. The method of claim 14, wherein the nucleotide 
sequence encoding a levansucrase contains a second copy of 
a sacB open reading frame. 
42-43. (canceled) 
44. The method of claim 15, wherein the nucleotide 
sequence encoding a levansucrase contains a second copy of 
a sacB open reading frame. 
